Chengdu Easton Biopharmaceuticals(688513) Stock Price Today

CN Stock MarketDetailed Quotes

Chengdu Easton Biopharmaceuticals (688513)

Watchlist

57.21
-0.74-1.28%

Market Closed Mar 9 15:00 CST

10.10BMarket Cap41.85P/E (TTM)

688513 Stock Chart

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

688513 Orderflow

Unit: --

688513 Orderflow Trend

IntradayDayWeekMonth

No Data

Chengdu Easton Biopharmaceuticals (688513) News

Yuan Dong Bio: Announcement of the 2025 Annual Performance Quick Report
SZSIFeb 27 11:00 ET · Announcements
Calculating The Fair Value Of Chengdu Easton Biopharmaceuticals Co., Ltd. (SHSE:688513)
Simply Wall StFeb 2 23:39 ET
Recent 6.4% Pullback Would Hurt Chengdu Easton Biopharmaceuticals Co., Ltd. (SHSE:688513) Insiders
Simply Wall StJan 15 19:08 ET
Chengdu Easton Biopharmaceuticals Co., Ltd.'s (SHSE:688513) Shareholders Might Be Looking For Exit
Simply Wall StDec 10, 2025 18:22 ET
Easton Biopharmaceuticals' Subsidiary Passes Two Inspections for Naloxone Hydrochloride Nasal Spray
MT NewswiresNov 28, 2025 01:52 ET
The One-year Decline in Earnings Might Be Taking Its Toll on Chengdu Easton Biopharmaceuticals (SHSE:688513) Shareholders as Stock Falls 5.3% Over the Past Week
Simply Wall StNov 19, 2025 18:47 ET

Chengdu Easton Biopharmaceuticals (688513) Stock Forum

Moomoo AI

Feb 6, 2024 13:04

Despite inferior earnings outlook, the company's P/E ratio aligns with most firms, indicating less bearish investor sentiment than analysts suggest. However, maintaining these prices may be challenging due to the weight of earnings growth on shares. Predicted future earnings may not support positive sentiment for long, risking shareholders' investments and potential investors paying an unnecessary premium.

Some Shareholders Feeling Restless Over Chengdu Easton Biopharmaceuticals Co., Ltd.'s (SHSE:688513) P/E Ratio